Zivo Bioscience Inc. Warrants (NASDAQ:ZIVOW) — Stock Price
Zivo Bioscience Inc. Warrants (NASDAQ:ZIVOW) is currently trading at $0.00 USD, down 97.78% today. Over the past 52 weeks, shares have ranged between $0.00 and $0.95. This page tracks Zivo Bioscience Inc. Warrants's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ZIVOW stock market capitalisation.
Zivo Bioscience Inc. Warrants (ZIVOW) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Zivo Bioscience Inc. Warrants's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Zivo Bioscience Inc. Warrants Income Statement — Revenue, Profit & Earnings by Year
Zivo Bioscience Inc. Warrants's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | $157.22K | $27.65K | $0.00 | $0.00 | $20.00K |
| Cost of Revenue | $108.27K | $16.04K | $0.00 | — | — |
| Gross Profit | $48.95K | $11.61K | $0.00 | — | $20.00K |
| Research & Development | $3.13 Million | $1.38 Million | $2.24 Million | $2.12 Million | $3.75 Million |
| SG&A | $10.28 Million | $5.90 Million | $6.49 Million | $6.93 Million | $4.82 Million |
| Total Operating Expenses | $13.41 Million | $7.27 Million | $8.73 Million | $9.05 Million | $8.58 Million |
| Operating Income | $-13.36 Million | $-7.26 Million | $-8.73 Million | $-9.05 Million | $-8.56 Million |
| EBITDA | $-13.36 Million | $-7.26 Million | $-8.73 Million | $-9.61 Million | $-8.56 Million |
| EBIT | — | $-7.70 Million | $-8.73 Million | $-9.05 Million | $-8.56 Million |
| Interest Expense | $22.94K | $514.17K | $13.32K | $233.28K | $550.05K |
| Income Before Tax | $-13.38 Million | $-7.78 Million | $-8.75 Million | $-9.16 Million | $-9.11 Million |
| Income Tax Expense | — | $-167.90K | $-4.00 | $233.28K | $550.05K |
| Net Income | $-13.38 Million | $-7.78 Million | $-8.75 Million | $-9.40 Million | $-9.66 Million |
Zivo Bioscience Inc. Warrants Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Zivo Bioscience Inc. Warrants's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | $1.64 Million | $555.72K | $2.12 Million | $8.99 Million | $220.18K |
| Total Current Assets | $1.64 Million | $425.38K | $1.90 Million | $8.96 Million | $167.81K |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $2.21K | $3.73K | $0.00 | — | — |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | $2.16 Million | $2.76 Million | $2.13 Million | $2.95 Million | $11.53 Million |
| Total Current Liabilities | $2.04 Million | $2.76 Million | $2.03 Million | $2.95 Million | $11.39 Million |
| Long-term Debt | $116.20K | — | — | — | $121.70K |
| Net Debt | $-1.29 Million | $71.96K | $-1.35 Million | $-8.65 Million | $5.22 Million |
| Total Stockholder Equity | $-514.90K | $-2.21 Million | $-10.62K | $6.04 Million | $-11.31 Million |
| Retained Earnings | $-136.97 Million | $-123.58 Million | $-115.80 Million | $-107.06 Million | $-99.06 Million |
Zivo Bioscience Inc. Warrants Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Zivo Bioscience Inc. Warrants generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-4.31 Million | $-5.80 Million | $-7.10 Million | $-6.80 Million | $-2.59 Million |
| Capital Expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Free Cash Flow | $-4.31 Million | $-5.80 Million | $-7.10 Million | $-6.80 Million | $-2.59 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | $5.58 Million | $4.28 Million | $-628.60K | $15.57 Million | $2.38 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | $9.47 Million | $867.36K | $2.69 Million | $2.97 Million | $1.25 Million |
| Depreciation | $98.28K | $439.59K | $-774.02K | $-555.75 Million | — |
| Change in Cash | $1.27 Million | $-1.52 Million | $-7.10 Million | $8.76 Million | $-208.25K |
Zivo Bioscience Inc. Warrants Earnings History — EPS Actual vs. Analyst Estimates
Track Zivo Bioscience Inc. Warrants's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for Zivo Bioscience Inc. Warrants.